Biothera | www.Biothera.com
Biothera Pharmaceuticals, Inc. has developed Imprime PGG which is a Pathogen Associated Molecular Patterning (PAMP) molecule that works like an immunological switch to coordinate innate and adaptive immune responses…
LocaLoop | www.LocaLoop.com
LocaLoop, Inc. has developed and is deploying in underserved, rural markets their own proprietary “turn-key” 4G wireless Internet system. They have designed a solution that integrates its cloud-based business and network management SaaS and IaaS platform, 4G hardware infrastructure, and subscriber-facing sales and support capabilities…
Empathic Software | www.Empathic.com
Empathic Clinical Suites is now being recognized as being a premier and best performing cloud based system for EMRs in the entire mental health industry. Also, they have added new functions and features including patient appointment scheduling, drug treatment plans, follow-up and all of the “back office” and financial functions needed to run multi-therapist mental health practices…
Space Data Corp | www.SpaceData.net
Space Data has developed and patented the technology for launching balloons into the stratosphere that can provide Internet connections and also cell phone coverage in very remote areas of the world…
Qualigen | www.QualigenInc.com
Qualigen is rapidly developing additional desktop blood testing systems for rapid blood tests. Sekisu Diagnostics, LLC a worldwide supplier of diagnostic equipment and compounds, is a major investor in Qualigen…
Alung | www.alung.com
ALung has developed an artificial lung support device that will replace ventilators for patients with chronic COPD and asthmatic disease. It is well on its way to having an FDA Expedited Access Pathway for full approval by late this year or early next year. Learn more about ALung at their website www.alung.com.
SaaSware Highway | www.SaaSware.com
SaaSware Highway owns small interests in Empathic and LocaLoop. We are waiting for liquidating events. When that happens, we intend to liquidate the Company and distribute the proceeds to the shareholders.
To learn more about these opportunities contact Paul Crawford at Crawford Capital Corp. email@example.com. (ofc) 612-676-1436 (cell) 612-308-6466.